Cardiology

A 63-year-old female presented to hospital with severe, central, sharp chest pain, exacerbated by deep inspiration and upon lying back. She denied cough, fever, or other systemic symptoms…

Prof Banach explained that current lipid-lowering therapy (LLT) with statins, ezetimibe, and proprotein convertase subtilisin/kexin Type 9 inhibitors…

PH encompasses a heterogeneous group of conditions, including PAH (Group 1), PH due to LHD (Group 2), PH due to lung diseases and/or hypoxia…

Advanced stage heart failure accounts for 1-10% of the overall heart failure population and the prevalence is increasing, in part because of…

European and USA treatment guidelines are aligned in their standard recommendation of therapies for symptomatic HFrEF. First-line…

REDUCE-IT was a Phase IIIb, double-blind, placebo-controlled trial that randomised 8,179 patients to receive icosapent ethyl (4 g/day) or placebo…

Acute myocardial infarction (AMI) is a common and life-threating condition. Approximately 10% of all emergency department (ED)…

Hypertrophic cardiomyopathy (HCM) is a progressive myocardial disease that impacts function and quality of life. Patients…

I went into cardiology to combine the science of medicine and the practical skills of surgery. I enjoy finding a problem and doing my best to fix it…

Life expectancy of patients with congenital heart disease (CHD) has increased in recent decades; however, late complications remain frequent and…

Heart failure (HF) represents a major public health issue, with prevalence approaching 2% in most European countries and considerable associated…

Haemophilus parainfluenzae has established itself as an important, albeit uncommon, cause of infective endocarditis (IE)…

The use of biomarkers has become routine in many areas of medicine. Knowing how and why these became incorporated into medical practice…

For >20 years, clinical trials have consistently demonstrated that the reduction of levels of low-density lipoprotein (LDL) cholesterol results in lower cardiovascular event rates, in both the primary and secondary prevention setting…

Catheter ablation is a well-established, safe, and effective treatment option for patients with atrial fibrillation (AF) and ventricular tachycardia (VT)…

Cardiac arrest during surgery is rare but is one of the most dreaded complications, particularly when there is no obvious underlying cause or risk…

HF is a global problem, with an estimated 63 million patients worldwide living with the disease.4 It is projected that the lifetime risk of developing…

Heart failure affects up to 26 million adults worldwide.1 The overall economic cost of heart failure in 2012 was estimated to be $108 billion per annum…

Atherosclerosis is an inflammatory disease and inflammation is crucial to all stages of atherogenesis. Targeting inflammation has the potential to reduce…

AF can increase stroke risk and is generally treated with OAC therapy, such as with a VKA or a direct OAC (DOAC). However, what if someone with AF…

PAH is a rare, progressive disorder with a number of aetiologies. Approximately 15–60 patients per million of the global population are affected…

Vascular calcification is an independent risk factor for cardiovascular disease (CVD). Calcium deposits in coronary arteries can weaken vasomotor…

Hypertrophic cardiomyopathy (HCM) is a progressive primary myocardial disorder characterised by unexplained left ventricular…

Pulmonary hypertension as a cause of right-sided heart failure and shock is often missed. In the intensive care patient population…

Cardiovascular diseases complicate approximately 0.2–4.0% of pregnancies.1 Their incidence is increasing…

Researchers that individually randomised controlled trials (iRCT) assume that the observed outcomes of participants…

This study aimed to investigate the role of ECG in pre-eclampsia diagnostics and simple clinical parameters in pre-eclampsia patients with and without…

Cardiac procedures and operations following pneumonectomy present with serious challenges, both surgical and anaesthetic…

An angiographic guidewire is a basic, yet key piece of equipment in the interventional cardiologist’s armamentarium. The complications associated…

This symposium brought together experts in cardiology, nephrology, diabetology, and clinical pharmacology to discuss best practice when caring for…

New guidelines for the diagnosis and management of chronic coronary syndromes (CCS)1 were released during the 2019 European Society of Cardiology (ESC) Congress.

Based on genetic evidence, it is now known that triglyceride-rich lipoproteins lead to atherosclerosis and local inflammation, which can result in…

Cardiac amyloidosis is a rare but life-threatening group of disorders caused by the extracellular deposition of misfolded amyloid fibrils in cardiac tissue.

The authors present a brief overview on the current role of cardiac rehabilitation among HF patients in a contemporary setting and discuss some areas of…

In this review, the authors present and discuss the scientific and clinical evidence pertaining to the role of Lp(a) in calcific aortic valve stenosis.

Atrial fibrillation (AF), the most common form of arrhythmia, increases the risk of heart failure, stroke, and death. Management of AF focusses on…

Atrial fibrillation (AF), the most common form of arrhythmia, is characterised by an irregular and often fast heart rhythm resulting in uncoordinated…

In the last two decades, the interest in tricuspid valve (TV) treatment has increased;1,2 nevertheless, there is still a large percentage…

In the late 20th century, lipid lowering medications appeared to be the answer for coronary heart disease. However, despite reductions in mortality…

A contemporary conceptual framework that was proposed to distinguish between different chronic heart failure (HF) patients has highlighted varying…